Efficacy and Safety of Nitazoxanide 600 Mg in the Outpatient Treatment of COVID-19 and Influenza
NCT06817096
·
clinicaltrials.gov ↗
PHASE3
Phase
NOT_YET_RECRUITING
Status
340
Enrollment
INDUSTRY
Sponsor class
Conditions
Covid 19
Influenza
Interventions
DRUG:
Nitazoxanide 600Mg Oral Tablet / placebo oral tablet
Sponsor
Azidus Brasil
Collaborators
[object Object]